BRD9 and acute myeloid leukemia: When tested in colony formation assays, BRD9 degrader- or inhibitor-treated primary AML cells completely failed to grow whereas colony formation with normal bone marrow-derived cultures were decreased by a modest 2-fold effect (Fig. 5B).